Xinhua Zou
58 Zhongshan 2nd Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features.
Journal: Cancer medicine
Published: December 30, 2022
Evaluating the Benefits of TACE Combined with Lenvatinib Plus PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Journal: Advances in therapy
Published: December 14, 2022
Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance.
Journal: Journal of hepatocellular carcinoma
Published: December 01, 2022
Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysis.
Journal: Cancer medicine
Published: March 08, 2022
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.
Journal: Journal of cancer research and clinical oncology
Published: February 04, 2022
Combined Use of Transjugular Intrahepatic Portosystemic Shunt and Transarterial Chemoembolization in the Treatment of Esophageal and Gastric Variceal Bleeding: A Retrospective Study of 80 Patients with Hepatocellular Carcinoma and Portal Hypertension.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: November 29, 2021
Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study.
Journal: American journal of cancer research
Published: June 16, 2021
Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression.
Journal: Cancer management and research
Published: January 30, 2021
Expression characterization and transcription regulation analysis of porcine Yip1 domain family member 3 gene.
Journal: Asian-Australasian journal of animal sciences
Published: January 23, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026